Breaking News Instant updates and real-time market news.

SPCE

Virgin Galactic

$28.69 /

-4.96 (-14.74%)

08:29
02/27/20
02/27
08:29
02/27/20
08:29

Morgan Stanley cuts Virgin Galactic as it waits for fundamentals to 'catch up'

As previously reported, Morgan Stanley analyst Adam Jonas downgraded Virgin Galactic to Equal Weight from Overweight with an increased price target of $30, up from $22. While "demand appears to be in no shortage" judging from registrations of interest having climbed to about 8,000, at current levels the stock "is nearly fully discounting a highly successful space tourism business at scale, a moderately successful space tourism business with early credit for the hypersonic opportunity, or a combination of both," Jonas tells investors. He lowered his rating as he waits for the fundamentals to "catch up" with the recent rally in the stock, Jonas noted. Credit Suisse analyst Robert Spingarn also downgraded Virgin Galactic to Neutral from Outperform this morning.

SPCE Virgin Galactic
$28.69 /

-4.96 (-14.74%)

02/27/20 Credit Suisse
Credit Suisse downgrades Virgin Galactic after 185% year-to-date rally
02/27/20 Credit Suisse
Virgin Galactic downgraded to Neutral from Outperform at Credit Suisse
02/27/20 Morgan Stanley
Virgin Galactic downgraded to Equal Weight from Overweight at Morgan Stanley
02/20/20 Morgan Stanley
Modest correction for Virgin Galactic overdue and 'healthy,' says Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks
Blueprint Medicines to submit FDA for pralsetinib in Q2 » 08:13
04/01/20
04/01
08:13
04/01/20
08:13
BPMC

Blueprint Medicines

$58.37 /

+0.41 (+0.71%)

Blueprint Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fidelity D & D Bancorp to hold special meeting of shareholders virtually » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
FDBC

Fidelity D & D Bancorp

$49.23 /

-0.77 (-1.54%)

Fidelity D & D…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
DexCom most defensive and best bounce back candidate, says Cowen » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
DXCM

DexCom

$269.45 /

-8.14 (-2.93%)

Cowen analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Finning International upgraded to Action List Buy from Buy at TD Securities » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
FINGF

Finning International

/

+

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
ShockWave Medical downgraded to Underperform at Oppenheimer » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
SWAV

ShockWave Medical

$33.11 /

-2.86 (-7.95%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
DA Davidson starts Zoom Video at Neutral citing 'rich valuation' » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
ZM

Zoom Video

$146.08 /

-4.82 (-3.19%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
PolarityTE appoints David Seaburg CEO, announces CFO Paul Mann to depart » 08:12
04/01/20
04/01
08:12
04/01/20
08:12
PTE

PolarityTE

$1.06 /

-0.03 (-2.75%)

PolarityTE announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
University of Applied Sciences Neu-Ulm selects Mediasite for online learning » 08:11
04/01/20
04/01
08:11
04/01/20
08:11
SOFO

Sonic Foundry

$0.00 /

+ (+0.00%)

The University of Applied…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Intuitive Surgical downgraded to Underperform at Oppenheimer » 08:10
04/01/20
04/01
08:10
04/01/20
08:10
ISRG

Intuitive Surgical

$495.27 /

-8.98 (-1.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Team17 downgraded to Underperform from Hold at Jefferies » 08:10
04/01/20
04/01
08:10
04/01/20
08:10
TSVNF

Team17

$0.00 /

+ (+0.00%)

Jefferies analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
MarketAxess expands global access for U.S. Taxable Municipal Bonds » 08:10
04/01/20
04/01
08:10
04/01/20
08:10
MKTX

MarketAxess

$332.57 /

-19.97 (-5.66%)

MarketAxess Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. ADP preview: » 08:10
04/01/20
04/01
08:10
04/01/20
08:10

U.S. ADP preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Diffusion Pharmaceuticals evaluating TSC against ARDS in COVID-19 » 08:09
04/01/20
04/01
08:09
04/01/20
08:09
DFFN

Diffusion Pharmaceuticals

$0.30 /

-0.033 (-9.79%)

Diffusion Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Paramount Group says impact of two transactions to cut FY20 FFO view by 3c » 08:09
04/01/20
04/01
08:09
04/01/20
08:09
PGRE

Paramount Group

$8.77 /

-0.06 (-0.68%)

Based on the expected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Federal Reserve Bank of Boston president participates in a webcast » 08:08
04/01/20
04/01
08:08
04/01/20
08:08

The Greater Boston…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Citius Pharmaceuticals signs exclusive option with Novellus » 08:08
04/01/20
04/01
08:08
04/01/20
08:08
CTXR

Citius Pharmaceuticals

$0.62 /

-0.0388 (-5.89%)

Citius Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Citi downgraded to Market Perform from Outperform at Keefe Bruyette » 08:08
04/01/20
04/01
08:08
04/01/20
08:08
C

Citi

$42.20 /

-1.89 (-4.29%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Epizyme downgraded to Perform at Oppenheimer » 08:08
04/01/20
04/01
08:08
04/01/20
08:08
EPZM

Epizyme

$15.41 /

-1.12 (-6.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
BNY Mellon upgraded to Outperform from Market Perform at Keefe Bruyette » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
BK

BNY Mellon

$33.68 /

-0.31 (-0.91%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Soliton postpones launch of RAP tattoo removal device » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
SOLY

Soliton

$7.95 /

-0.48 (-5.69%)

Soliton provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Dare Bioscience receives third notice of award from NIH division for Ovaprene » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
DARE

Dare Bioscience

$0.86 /

-0.0345 (-3.87%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

Dare Bioscience (DARE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
JPMorgan upgraded to Outperform from Market Perform at Keefe Bruyette » 08:07
04/01/20
04/01
08:07
04/01/20
08:07
JPM

JPMorgan

$90.30 /

-3.14 (-3.36%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Semtech participates in a conference call with Piper Sandler » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
SMTC

Semtech

$37.48 /

+0.79 (+2.15%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
State Street downgraded to Market Perform from Outperform at Keefe Bruyette » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
STT

State Street

$53.18 /

+2.45 (+4.83%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Heat Biologics announces formation of COVID-19 advisory board » 08:06
04/01/20
04/01
08:06
04/01/20
08:06
HTBX

Heat Biologics

$0.57 /

-0.0026 (-0.45%)

Heat Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.